Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms
VITALITY
Endovascular Repair Using the Talent™ Abdominal Stent Graft System in Abdominal Aortic Aneurysms (VITALITY)
1 other identifier
interventional
94
1 country
18
Brief Summary
The purpose of this study is to examine, through the endpoints established in this protocol, the long-term safety and effectiveness of the Talent Abdominal Stent Graft System, in a post-approval environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2008
Longer than P75 for not_applicable
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 29, 2008
CompletedFirst Posted
Study publicly available on registry
December 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedResults Posted
Study results publicly available
January 23, 2018
CompletedOctober 29, 2021
October 1, 2021
6.6 years
December 29, 2008
August 1, 2016
October 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Freedom From Aneurysm-related Mortality (ARM)
ARM is defined as death from rupture of the abdominal aortic aneurysm or from any procedure intended to treat the Abdominal Aortic Aneurysm (AAA). If a death occurred within 30 days of any procedure intended to treat the AAA, then it is presumed to be aneurysm related unless there is evidence to the contrary. Deaths occurring after 30 days of any procedure intended to treat the AAA that are procedure-related should also be aneurysm related. All deaths were adjudicated by a Clinical Events Committee (CEC) to determine aneurysm, device and/or procedure relatedness.
5 year Kaplan Meier (KM)
Study Arms (1)
Treatment
EXPERIMENTALPatients diagnosed with an abdominal aortic or aorto-iliac aneurysm that are considered candidates for endovascular repair, per the FDA approved IFU.
Interventions
The Talent Abdominal Stent Graft is indicated for the endovascular treatment of abdominal aortic aneurysms with or without iliac involvement.
Eligibility Criteria
You may qualify if:
- Subject must have an abdominal aortic aneurysm, with or without iliac involvement.
- Iliac/femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;
- A proximal aortic neck length of ≥ 10mm;
- Proximal aortic neck angulation ≤ 60°;
- Distal iliac artery fixation length of ≥ 15mm;
- An aortic neck diameter of 18-32mm and iliac artery diameters of 8-22mm; and
- Vessel morphology suitable for endovascular repair.
You may not qualify if:
- Are less than 18 years of age
- Are pregnant or lactating
- Have a dominant patent inferior mesenteric artery and an occluded or stenotic celiac and/or superior mesenteric artery
- Have aneurysmal involvement or occlusion (surgically performed or naturally occurring) of the bilateral internal iliac arteries
- Have vessels and/or aneurysm dimensions that cannot accommodate the Talent Abdominal Stent Graft as per the indications in Section 3.
- Have no distal vascular bed (one vessel lower extremity run-off required)
- Have contraindications for use of contrast medium or anticoagulation drugs
- Have an uncorrectable coagulopathy
- Have an SVS/AAVS score greater than 2
- Have a mycotic aneurysm
- Have circumferential mural thrombus in the proximal aortic neck
- Have had a recent (within 3 months) myocardial infarction (MI), cerebral vascular accident (CVA), or major surgical intervention
- Have traumatic aortic injury
- Have leaking, pending rupture or ruptured aneurysms
- Have pseudoaneurysms resulting from previous graft placement
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
USC Univerisity Hospital
Los Angeles, California, 90033, United States
Palo Alto VAMC
Palo Alto, California, 94304, United States
Christiana Care Health Services
Newark, Delaware, 19713, United States
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
St. John's Medical Research Institute
Springfield, Missouri, 65810, United States
Barnes Jewish
St Louis, Missouri, 63110, United States
East Carolina University
Greenville, North Carolina, 27834, United States
Forsyth Medical Center
Winston-Salem, North Carolina, 27103, United States
Lehigh Valley Hospital
Allentown, Pennsylvania, 18103, United States
Pinnacle Health Network
Harrisburg, Pennsylvania, 17110, United States
Sanford USD Medical Center
Sioux Falls, South Dakota, 57104, United States
North Central Heart Institute
Sioux Falls, South Dakota, 57108, United States
St. Mary's Medical Center
Knoxville, Tennessee, 37923, United States
Vanderbilt Vascular Surgery
Nashville, Tennessee, 37232, United States
Wilford Hall Medical Center
Lackland Air Force Base, Texas, 78236, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042, United States
Charleston Area Medical Center
Charleston, West Virginia, 23504, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Rianna Rapson
- Organization
- Medtronic
Study Officials
- PRINCIPAL INVESTIGATOR
Luis Sanchez, MD
Washington University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2008
First Posted
December 31, 2008
Study Start
December 1, 2008
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
October 29, 2021
Results First Posted
January 23, 2018
Record last verified: 2021-10